Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

The 3 Safest Stocks to Buy in the Market Now

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signaled to continue raising rates through next year, with no expectations to cut rates until 2024. The Fed’s hawkish stance and rising recessionary fears have dampened investor sentiment lately. Given the backdrop,…

StockNews.com

Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

The drug is the most effective way to cut the risk of severe disease. It's heading to China now. Yet the drug is underused in some places. Why? And are there options if you're not a good candidate?

WEKU

RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

For many parents, respiratory syncytial virus – or RSV – which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is a common respiratory virus that circulates every fall and winter and…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer to sell Paxlovid in China as COVID cases surge

Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.

Tribune News Service

2 years after Kentucky’s first COVID-19 vaccines, doctors continue to urge people to get vaxxed

WEKU

China has a new strategy for keeping official COVID numbers down during its reopening: Stop counting many new infections

With mandatory testing dropped, it can no longer accurately gauge the number of people who have COVID but don’t have symptoms, its National Health Commission said.

Fortune

DeSantis demands COVID vax grand jury

Doctors "outraged" after DeSantis pushes investigation and truther panel to refute CDC public health guidance

Salon

Read news from The Economist, FT, and more,
with one subscription

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to improve their effectiveness, including how they’re administered. Immunologist and microbiologist Michael W. Russell of the University at…

The Conversation

China says spread of Covid ‘impossible’ to track as infections soar in Beijing

Health officials cease recording asymptomatic cases as shortages of medical supplies and testing kits reported in wake of sudden end to strict Covid policy

The Guardian - AU

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

Fortune

Paxlovid has been free so far. Next year, sticker shock awaits

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill…

Tribune News Service

3 High-Yield Dividend Stocks With Upside Potential Right Now

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

StockNews.com

COVID, flu, RSV: The benefits of advocating for boosters in the workplace–and how to go about it

The return to the office has turned into a superspreader event.

Fortune

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Omicron-fighting COVID vaccine authorized for kids as young as 6 months

The omicron-fighting COVID-19 vaccine is now approved for children ages 6 months and older, the U.S. Food and Drug Administration said Thursday.

Los Angeles Times

Michael Hiltzik: Rescinding the military's COVID vaccine rule is the Democrats' dumbest compromise in the lame-duck session

If you need evidence that Congress is dominated by its stupidest members, look no further than the apparent agreement in the House to lift the requirement that members of the military be vaccinated against COVID-19.

Chicago Sun-Times

Paxlovid free so far, but sticker shock awaits next year if you need the COVID treatment

Within months, the government plans to stop footing the bill — and millions of the uninsured and seniors might have to pay full price. Experts say that means fewer people will get the potentially life-saving treatments.

The Independent UK

Tory MP urged to apologise and correct record on ‘dangerous’ Covid vaccine claim

Andrew Bridgen described mRNA vaccines as ‘experimental’.

Get all your
news in one place.

100's of premium titles.
One news app.

Newsroom.co.nz

A bitter pill to swallow: Family calls for health changes a year on from daughter’s sudden death

A coroner has found the contraceptive pill may have led to 17-year-old Isabella Alexander's death - and now her family are calling for changes to how it’s prescribed.

The Philadelphia Inquirer

Penn scientists made a universal flu vaccine using mRNA, and they plan to test it in humans

PHILADELPHIA — For years, scientists have tried, and failed, to make a one-and-done vaccine that would provide at least partial protection against all types of the flu.

Wales Online

Covid vaccines for babies as young as six months as UK approves Pfizer jab

Children between the age of six months and four years will receive a dose 10 times lower than that of the adult jab

Daily Mirror

UK approves Covid vaccines for babies as young as six months could soon get Pfizer jab

Britain's health regulator has today authorised the Pfizer vaccine for infants as young as six months, as the decision opens the door for advisers to choose whether the jab should be given to under-fives

Evening Standard

Covid: UK health regulator backs Pfizer/BioNTech vaccine for babies as young as six months

The move opens the door to vaccinating the country’s youngest children should the Joint Committee on Vaccination and Immunisation agree

Tribune News Service

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Tribune News Service

Pfizer to invest $750M in Kalamazoo area facility, add hundreds of new jobs

LANSING, Michigan— Pharmaceutical giant Pfizer Inc. will invest $750 million in its southwest Michigan facility to increase capacity for manufacturing sterile injectable medications, creating 300 new jobs, the company announced Monday.

1 … 31 32 33 34

People

Mangeet Kaur BounsMangeet

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.